Get started
Author

K. Wang

OpenAlex ID: A5001237761
A phase II trial of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2019 · E. Zsiros, P.J. Frederick, et al. · Gynecologic Oncology · 17
P-156 A phase Ib/II study of cetuximab and pembrolizumab in metastatic colorectal cancer
2020 · C. Fountzilas, S. Mukherjee, et al. · Annals of Oncology · 3
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
2024 · N.K. Malik, M.K. Farrugia, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience
2016 · S.J. Ma, J. Gomez Suescun, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
A 1-Year Prospective Study Evaluating Adherence to Oral Oncolytics in Older Adults with Lymphoma
2023 · P. Torka, O. Akhtar, et al. · Journal of Geriatric Oncology
Association between Geriatric Impairments and Quality of Life in Older Adults with Lymphoma on Oral Targeted Therapies: A One‐Year Prospective Study
2023 · P. Torka, O. Akhtar, et al. · Hematological Oncology
PDF
103P Temporospatial heterogeneity in metastatic colorectal cancer (mCRC)
2020 · C. Fountzilas, A. Witkiewicz, et al. · Annals of Oncology
PDF
P2.15-24 Comparison of Pemetrexed Administered q 3 Weeks vs q 4 Weeks as Maintenance Therapy in NSCLC: Analysis of Real World Data from a Single Institution
2018 · G. Dy, S. Reddy, et al. · Journal of Thoracic Oncology
Works count: 8
Citation count: 22
H-index: 2
I10-index: 1
Year
Topic
Type